This study provides Class IV evidence that rituximab is an effective treatment for some types of AE.
No takes yet. Share an insight, caveat, or question.
Thaler et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: